Castle Biosciences
CSTL
CSTL
180 hedge funds and large institutions have $516M invested in Castle Biosciences in 2025 Q1 according to their latest regulatory filings, with 30 funds opening new positions, 76 increasing their positions, 54 reducing their positions, and 43 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
9% less funds holding
Funds holding: 197 → 180 (-17)
27% less capital invested
Capital invested by funds: $706M → $516M (-$190M)
30% less first-time investments, than exits
New positions opened: 30 | Existing positions closed: 43
Holders
180
Holding in Top 10
2
Calls
$200K
Puts
$112K
Top Buyers
| 1 | +$11.9M | |
| 2 | +$11.1M | |
| 3 | +$9.78M | |
| 4 |
B
Braidwell
Stamford,
Connecticut
|
+$7.31M |
| 5 |
Allianz Asset Management
Munich,
Germany
|
+$6.35M |
Top Sellers
| 1 | -$16M | |
| 2 | -$15.3M | |
| 3 | -$11.5M | |
| 4 |
BG
Bellevue Group
Kuesnacht,
Switzerland
|
-$8.91M |
| 5 |
SCM
Soleus Capital Management
Greenwich,
Connecticut
|
-$6.74M |
